Diagonal Bio AB (DIABIO) — Net Asset Quality Index
Diagonal Bio AB (DIABIO) has a Net Asset Quality Index of 92.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr29.10 Million minus total liabilities of Skr2.13 Million yields net assets of Skr26.97 Million. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Diagonal Bio AB to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Diagonal Bio AB Net Asset Quality Index Over Time (2020–2024)
This chart shows how Diagonal Bio AB's Net Asset Quality Index has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the index stands at 92.7%, representing net assets of Skr26.97 Million against total assets of Skr29.10 Million SEK. Explore cash flow conversion of Diagonal Bio AB to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Diagonal Bio AB (2020–2024)
The table below presents the year-by-year Net Asset Quality Index for Diagonal Bio AB from 2020 to 2024, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see DIABIO stock market capitalisation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 90.6% | Skr24.59 Million | Skr27.13 Million | Skr2.54 Million | ▲ +16.1 pp |
| 2023 | 74.5% | Skr21.25 Million | Skr28.51 Million | Skr7.26 Million | ▼ -17.3 pp |
| 2022 | 91.8% | Skr31.25 Million | Skr34.03 Million | Skr2.78 Million | ▼ -2.2 pp |
| 2021 | 94.0% | Skr33.87 Million | Skr36.01 Million | Skr2.14 Million | ▲ +4.9 pp |
| 2020 | 89.2% | Skr8.89 Million | Skr9.97 Million | Skr1.08 Million | — |